🔗 Share this article

The Nobel Prize in medical science has been granted for revolutionary findings that illuminate how the body's defense network targets harmful pathogens while protecting the healthy tissues.

A trio of renowned researchers—from Japan Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this honor.

The work uncovered specialized "security guards" within the defense system that eliminate rogue immune cells capable of harming the organism.

These findings are now enabling new treatments for autoimmune diseases and malignancies.

These winners will divide a monetary award valued at 11m Swedish kronor.

Decisive Discoveries

"Their work has been essential for comprehending how the immune system functions and why we don't all suffer from serious autoimmune diseases," stated the head of the award panel.

The trio's studies explain a core question: How does the defense system protect us from numerous invaders while keeping our own tissues unharmed?

Our body's protection system employs immune cells that search for indicators of disease, including viruses and germs it has not met before.

These cells employ detectors—known as recognition units—that are produced by chance in a vast number of combinations.

That gives the immune system the capacity to fight a wide array of threats, but the randomness of the mechanism inevitably creates white blood cells that can target the host.

Protectors of the Immune System

Researchers earlier knew that a portion of these problematic white blood cells were destroyed in the immune organ—the site where white blood cells develop.

The latest Nobel Prize honors the discovery of T-reg cells—known as the body's "security guards"—which travel through the system to neutralize other defenders that assault the body's own tissues.

We know that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

A prize committee added, "These findings have established a novel area of investigation and spurred the development of innovative treatments, for instance for tumors and immune disorders."

In malignancies, regulatory T-cells block the system from attacking the tumor, so research are aimed at lowering their quantity.

For self-attack disorders, trials are testing increasing regulatory T-cells so the body is not under attack. A similar method could also be effective in minimizing the chances of organ transplant rejection.

Pioneering Experiments

Prof Sakaguchi, of a Japanese institution, performed tests on rodents that had their immune gland removed, leading to autoimmune disease.

He demonstrated that introducing defense cells from other animals could prevent the illness—implying there was a mechanism for preventing immune cells from attacking the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an inherited immune disorder in rodents and people that led to the discovery of a genetic factor vital for how regulatory T-cells function.

"Their pioneering work has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally targeting the healthy cells," commented a leading physiology specialist.

"This research is a remarkable example of how basic physiological research can have broad consequences for public health."